Free Trial

INVO Bioscience (INVO) SEC Filings & 10K Form

$0.93
-0.06 (-6.07%)
(As of 05/20/2024 ET)

Recent INVO Bioscience SEC Filings

DateFilerForm TypeView
05/15/2024
3:51 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:30 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:43 PM
INVO Bioscience (Filer)
Form 10-K/A
04/19/2024
4:18 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:02 PM
INVO Bioscience (Filer)
Form 10-K/A
04/17/2024
2:15 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:50 PM
INVO Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/16/2024
3:56 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
4:28 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
4:19 PM
INVO Bioscience (Filer)
Form 8-K/A
04/01/2024
3:18 PM
INVO Bioscience (Filer)
Form NT 10-K
03/29/2024
3:41 PM
INVO Bioscience (Filer)
Form 424B5
03/27/2024
4:24 PM
INVO Bioscience (Filer)
Form 10-K/A
03/01/2024
4:16 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
9:24 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
INVO Bioscience (Subject)
Form SC 13G/A
02/01/2024
8:01 AM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
4:29 PM
INVO Bioscience (Filer)
Form S-4
Registration statement under Securities Act of 1933  
01/10/2024
3:46 PM
INVO Bioscience (Filer)
Form 8-K/A
01/03/2024
4:29 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
4:02 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
4:04 PM
INVO Bioscience (Filer)
Form 424B7
12/27/2023
4:45 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
4:08 PM
INVO Bioscience (Filer)
Form DEFA14A
12/13/2023
3:53 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
4:18 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
12:08 PM
INVO Bioscience (Filer)
Form DEF 14A
11/13/2023
8:21 AM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:23 AM
INVO Bioscience (Subject)
Form SC TO-C
11/13/2023
8:12 AM
INVO Bioscience (Filer)
Form PRE 14A
10/24/2023
4:10 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
5:15 AM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:28 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
4:24 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
4:12 PM
INVO Bioscience (Filer)
Form DEFA14A
09/29/2023
4:26 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
11:45 AM
INVO Bioscience (Filer)
Form DEFA14A
09/08/2023
3:34 PM
AWM Investment Company, Inc. (Filed by)
INVO Bioscience (Subject)
Form SC 13G/A
09/01/2023
4:17 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
8:55 AM
INVO Bioscience (Filer)
Form DEF 14A
08/21/2023
3:33 PM
INVO Bioscience (Filer)
Form PRE 14A
08/11/2023
1:07 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.
08/03/2023
11:15 PM
INVO Bioscience (Filer)
Form EFFECT
08/02/2023
11:58 AM
INVO Bioscience (Filer)
Form S-1/A
07/31/2023
5:06 AM
INVO Bioscience (Filer)
Form S-1/A
07/31/2023
5:15 AM
INVO Bioscience (Subject)
Form FWP
07/27/2023
4:16 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
5:13 AM
INVO Bioscience (Filer)
Form S-1/A
07/21/2023
4:50 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
4:29 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
3:05 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
1:37 PM
INVO Bioscience (Filer)
Form 424B3
07/09/2023
11:15 PM
INVO Bioscience (Filer)
Form EFFECT
07/07/2023
3:17 PM
INVO Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
12:43 PM
INVO Bioscience (Filer)
Form S-1/A
06/30/2023
4:23 PM
INVO Bioscience (Filer)
Form 8-K/A
06/23/2023
3:06 PM
INVO Bioscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/21/2023
11:55 AM
INVO Bioscience (Filer)
Form 8-K/A
05/22/2023
6:56 PM
Campbell Michael Jos. (Reporting)
INVO Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
6:58 PM
DAVIS TRENT D (Reporting)
INVO Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
7:01 PM
Goren Andrea (Reporting)
INVO Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
7:04 PM
INVO Bioscience (Issuer)
Messina Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
7:07 PM
INVO Bioscience (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
7:09 PM
INVO Bioscience (Issuer)
Shum Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
7:13 PM
INVO Bioscience (Issuer)
Szot Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INVO) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners